3atw: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3atw.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3atw", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3atw| PDB=3atw | SCENE= }} | |||
===Structure-Based Design, Synthesis, Evaluation of Peptide-mimetic SARS 3CL Protease Inhibitors=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22014094}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22014094 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22014094}} | |||
==About this Structure== | |||
[[3atw]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Sars_coronavirus Sars coronavirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ATW OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022014094</ref><references group="xtra"/> | |||
[[Category: SARS coronavirus main proteinase]] | |||
[[Category: Sars coronavirus]] | |||
[[Category: Akaji, K.]] | |||
[[Category: Hattori, Y.]] | |||
[[Category: Konno, H.]] | |||
[[Category: Kusunoki, M.]] | |||
[[Category: Mitsui, H.]] | |||
[[Category: Ozaki, T.]] | |||
[[Category: Sanjho, A.]] | |||
[[Category: Teruya, K.]] | |||
[[Category: Designed inhibitor]] | |||
[[Category: Hydrase proteinase converting]] | |||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
Revision as of 11:38, 14 December 2011
Structure-Based Design, Synthesis, Evaluation of Peptide-mimetic SARS 3CL Protease Inhibitors
Template:ABSTRACT PUBMED 22014094
About this Structure
3atw is a 4 chain structure with sequence from Sars coronavirus. Full crystallographic information is available from OCA.
Reference
- Akaji K, Konno H, Mitsui H, Teruya K, Shimamoto Y, Hattori Y, Ozaki T, Kusunoki M, Sanjoh A. Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors. J Med Chem. 2011 Dec 8;54(23):7962-73. Epub 2011 Nov 9. PMID:22014094 doi:10.1021/jm200870n
